Citigroup’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $778K | Sell |
33,690
-42,592
| -56% | -$984K | ﹤0.01% | 2651 |
|
|
2025
Q1 | $2.06M | Sell |
76,282
-3,264
| -4% | -$88.1K | ﹤0.01% | 2063 |
|
|
2024
Q4 | $4.26M | Buy |
79,546
+58,070
| +270% | +$3.11M | ﹤0.01% | 1550 |
|
|
2024
Q3 | $976K | Buy |
21,476
+5,881
| +38% | +$267K | ﹤0.01% | 2578 |
|
|
2024
Q2 | $653K | Sell |
15,595
-25,977
| -62% | -$1.09M | ﹤0.01% | 2533 |
|
|
2024
Q1 | $1.57M | Buy |
41,572
+37,745
| +986% | +$1.42M | ﹤0.01% | 2015 |
|
|
2023
Q4 | $41.1K | Buy |
3,827
+3,337
| +681% | +$35.8K | ﹤0.01% | 3874 |
|
|
2023
Q3 | $4.94K | Sell |
490
-5,297
| -92% | -$53.4K | ﹤0.01% | 3991 |
|
|
2023
Q2 | $68.7K | Buy |
5,787
+5,228
| +935% | +$62.1K | ﹤0.01% | 3778 |
|
|
2023
Q1 | $6.76K | Buy |
559
+162
| +41% | +$1.96K | ﹤0.01% | 4190 |
|
|
2022
Q4 | $5.23K | Sell |
397
-588
| -60% | -$7.74K | ﹤0.01% | 4293 |
|
|
2022
Q3 | $13K | Sell |
985
-1,166
| -54% | -$15.4K | ﹤0.01% | 4168 |
|
|
2022
Q2 | $26K | Buy |
2,151
+301
| +16% | +$3.64K | ﹤0.01% | 4166 |
|
|
2022
Q1 | $27K | Sell |
1,850
-2,934
| -61% | -$42.8K | ﹤0.01% | 4274 |
|
|
2021
Q4 | $94K | Buy |
4,784
+3,029
| +173% | +$59.5K | ﹤0.01% | 4001 |
|
|
2021
Q3 | $38K | Sell |
1,755
-84,940
| -98% | -$1.84M | ﹤0.01% | 4145 |
|
|
2021
Q2 | $2.16M | Buy |
+86,695
| New | +$2.16M | ﹤0.01% | 2044 |
|